Latest Articles

  • Statins in acute coronary syndromes: Start them in the hospital
    Monica Acevedo, MD and Dennis L. Sprecher, MD
    Cleveland Clinic Journal of Medicine January 2002, 69 (1) 25-37;

    New data indicate statins should be started as soon as possible in acute coronary syndromes. Current guidelines may need to be changed.

  • Surgery for fibromyalgia (April 2001)
    Alexander C. Chester, MD
    Cleveland Clinic Journal of Medicine January 2002, 69 (1) 89;
  • In reply: Human herpesvirus 6 (July 2001)
    Roy F. Chemaly, MD and Susan J. Rehm, MD
    Cleveland Clinic Journal of Medicine January 2002, 69 (1) 92;
  • Cultural and clinical issues in the care of Asian patients
    Xian Wen Jin, MD, PhD, Jacquelyn Slomka, PhD, RN and Carol E. Blixen, PhD, RN
    Cleveland Clinic Journal of Medicine January 2002, 69 (1) 50-61;

    Three case studies that illustrate some of the special problems affecting the health care of Asian patients and ways to deal with them constructively.

  • GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
    Derek P. Chew, MBBS and David J. Moliterno, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 1017-1023;

    Recent trials addressed whether there are clinical differences among these drugs, whether their empiric use is justified in acute coronary syndromes, and whether they might allow for early invasive management in acute coronary syndromes.

  • Index to Volume 68
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 1024-1028;
  • Bioterrorism: What practicing physicians can do
    James C. Pile, MD and David L. Longworth, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 998-1000;

    Given the specter of biological terrorism, the medical system has much to learn and much to do to prepare.

  • Our new understanding of pulmonary alveolar proteinosis: What an internist needs to know
    Our new understanding of pulmonary alveolar proteinosis: What an internist needs to know
    Peter Mazzone, MD, Mary Jane Thomassen, PhD and Mani Kavuru, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 977-993;

    Recent advances point to a defect in granulocyte-macrophage colony stimulating factor (GM-CSF) as a cause of this disease. New treatments are under study.

  • A 62-year-old man with an abnormal electrocardiogram
    Curtis M. Rimmerman, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 975-976;

    Questions and answers on the visible signs of diseases.

  • Biological and chemical terrorism: Recognition and management
    Thomas P. Noeller, MD
    Cleveland Clinic Journal of Medicine December 2001, 68 (12) 1001-1016;

    Future terrorist attacks might involve a variety of chemical or biological agents, including nerve agents, blistering agents, hydrogen cyanide, ricin, anthrax, smallpox, plague, and botulinum toxin. Physicians are on the front line.

Pages